Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test Recalled by PROTERIXBIO Due to FDA review concluded that the test is insufficiently...

Date: April 17, 2022
Company: PROTERIXBIO
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact PROTERIXBIO directly.

Affected Products

ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, no model number

Quantity: 640 kits

Why Was This Recalled?

FDA review concluded that the test is insufficiently supported by clinical performance data, and results reported may not have been accurate (false positives or false negatives).

Where Was This Sold?

This product was distributed to 12 states: CA, CO, FL, IA, MA, MO, NH, NY, OH, OK, TX, VA

Affected (12 states)Not affected

About PROTERIXBIO

PROTERIXBIO has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report